Additionally, immune responses against myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) have been associated with larger cerebral infarctions and increased the likelihood of worse outcome in stroke patients [53,55]. This evidence concerns the gene MBP and cerebral infarction.